Lori Linke

A wearable artificial kidney for patients with end-stage renal disease

Victor Gura, Matthew B. Rivara, Scott D. Bieber et al. · JCI Insight · 2016 · 170 citations · Full text

Medicine, Bioengineering, Nephrology +13

Safety and cardiovascular efficacy of spironolactone in dialysis-dependent ESRD (SPin-D): a randomized, placebo-controlled, multiple dosage trial

David M. Charytan, Jonathan Himmelfarb, T. Alp İkizler et al. · Kidney International · 2018 · 102 citations

Medicine, Nephrology, Pharmacology +12

Effect of Coenzyme Q10 on Biomarkers of Oxidative Stress and Cardiac Function in Hemodialysis Patients: The CoQ10 Biomarker Trial

Matthew B. Rivara, Catherine K. Yeung, Cassianne Robinson‐Cohen et al. · American Journal of Kidney Diseases · 2016 · 63 citations · Full text

Medicine, Cardiology, Nephrology +17

Coenzyme Q10 dose-escalation study in hemodialysis patients: safety, tolerability, and effect on oxidative stress

Catherine K. Yeung, Frederic T. Billings, Adam J. Claessens et al. · BMC Nephrology · 2015 · 62 citations · Full text

Medicine, Nephrology, Pharmacology +14

Rationale and design of A Trial of Sertraline vs. Cognitive Behavioral Therapy for End-stage Renal Disease Patients with Depression (ASCEND)

S. Susan Hedayati, Divya M. Daniel, Scott Cohen et al. · Contemporary Clinical Trials · 2015 · 48 citations

Pharmacy, Pharmacology, Pharmacotherapy +9